NASA WARNING CNN NEWS YouTube
By: 007tv1
Read the original here:
NASA WARNING CNN NEWS YouTube
By: 007tv1
Read the original here:
NASA: Operation IceBridge Gets Mission in 3 Minutes
Further videos about topics addressed are available in favourites, play lists on my channel and complementary video responses. Mirrored: http://www.youtube.com Can you stuff all the sights and science of a 12-hour mission into just three minutes? Maybe not, but here #39;s our first try, chronicling NASA #39;s recent flight to Antarctica #39;s remote Getz Ice Shelf, where Operation IceBridge measured everything from the ice surface to the bedrock below, flew low over giant icebergs, and even scanned a lengthy new crack in the ice.
By: MsWingmaker
Read this article:
A NASA top official wrestled with what he thought was a hypothetical question: What should you tell the astronauts of a doomed space shuttle Columbia?
When the NASA official raised the question in 2003 just days before the accident that claimed seven astronauts' lives, managers thought wrongly that Columbia's heat shield was fine. It wasn't.
Columbia, NASA's oldest shuttle, broke apart over Texas 10 years ago Friday upon returning to Earth after a 16-day mission.
But the story of that question retold a decade later illustrates a key lesson from the tragedy, says Wayne Hale, a flight director who later ran the shuttle program for NASA.
That lesson: Never give up. No matter how hopeless.
And to illustrate the lesson, Hale in his blog tells for the first time the story of his late boss who seemingly suggested doing just that. The boss, mission operations chief Jon Harpold, asked the now-retired Hale a what-if question after a meeting that determined wrongly that Columbia was safe to land despite some damage after takeoff.
Space shuttle program manager Wayne Hale, shown here in a 2007 photo, said NASA would have tried to save the Columbia's crew had it realized the true severity of the problem with the heat shield. (Wildfredo Lee/Associated Press)"You know there is nothing we can do about damage to the (thermal protection system)," Hale quotes Harpold a decade later.
"If it has been damaged, it's probably better not to know. I think the crew would rather not know. Don't you think it would be better for them to have a happy successful flight and die unexpectedly during entry than to stay on orbit, knowing that there was nothing to be done until the air ran out."
When Harpold raised the question with Hale in 2003, managers had already concluded that Columbia's heat shield was fine.
They told astronauts they weren't worried about damage from foam insulation coming off the massive shuttle fuel tank during launch, hitting a wing that allowed superheated gases in when the shuttle re-entered the atmosphere. No one was aware of the seriousness of the damage at the time.
See the rest here:
A NASA spacecraft studying the sun has recorded amazing video of a giant plume of super-hot plasma erupting from the star's surface, only to crash back down hours later.
The solar plasma eruption, which NASA scientists nicknamed a "Dragon Tail," rose up from the sun's surface today (Jan. 31) and was spotted by the agency's Solar Dynamics Observatory, a powerful spacecraft that constantly records the sun's weather in different wavelengths of light.
A video of the Dragon Tail solar eruption shows a tendril of solar plasma, which scientists call a "filament," extending across the northeastern face of the sun over the course of four hours. Near the end of the event, the filament begins to break apart.
"Some of the plasma was released into space but not all could escape the gravitational pull of the sun," SDO mission officials explained in a video description. "It's not surprising that plasma should fall back to the sun. After all, the sun's gravity is powerful."
Filaments are plasma formations on the sun sculpted by the star's intense magnetic field, with one end anchored to the sun's surface. The other end can extend through the sun's outer atmosphere, called the corona, hundreds of thousands of miles into space.
Filament structures typically last about a single day, though stable ones can exist for months at a time, SDO officials explained. The plasma in filaments consists of super-hot helium and hydrogen that is electrically charged, they added.
NASA's Solar Dynamics Observatory is one of several spacecraft constantly monitoring the sun for signs of solar flares, eruptions and other space weather events. The sun is currently in an active phase of its 11-year solar weather cycle and is expected to reach its peak activity period in 2013. The current sun weather cycle is known as Solar Cycle 24.
You can follow SPACE.com Managing Editor Tariq Malik on Twitter@tariqjmalik.Follow SPACE.com for the latest in space science and exploration news on Twitter@Spacedotcomand onFacebook.
See the original post:
ARLINGTON, Va., Feb. 1, 2013 /PRNewswire/ --NASA and ATK (ATK) completed the second in a series of development tests for NASA's Space Launch System (SLS) booster program on January 30 at ATK's Promontory, Utah, test facility. This key avionics and controls test was designated Flight Control Test 2 (FCT-2) and included a "hot fire" of the fully integrated heritage thrust vector control (TVC), the new SLS booster avionics subsystem and new electronic support equipment (ESE).
FCT-2 focused on replacement of heritage test equipment with new ESE. Much of the equipment replaced was designed and built during the mid- to late-1970s and was successfully used on all Space Shuttle Reusable Solid Rocket Motor (RSRM) and five segment RSRM static motor firings.
"The FCT-2 test marked a definite milestone for ATK and NASA's SLS program," said Fred Brasfield, ATK's vice president, Next-Generation Booster. "Working with Marshall, we have designed and developed a modern system and common interface that allows for multiple uses of the same equipment at all necessary locations for both qualification and operational phases of the program, greatly reducing complexity and costs."
As with the avionics subsystem, affordability was designed in from the onset of developing new ESE. The same ESE design utilized to support static tests will also be used to support certification testing of the avionics subsystem in Utah and at NASA's Marshall Space Flight Center, and ultimately for acceptance check-out of flight hardware at Kennedy Space Center (KSC).
ATK developed the avionics subsystem at facilities in Clearfield and Magna, Utah, with support from NASA Marshall Space Flight Center in Alabama.Key partners supporting ATK throughout this test series include L-3 Cincinnati Electronics in Mason, Ohio, and Southern California Braiding, an IEC Electronics Company in Bell Gardens, California.Cincinnati Electronics provides the avionics boxes, and Southern California Braiding is responsible for the cable harnesses. Both Cincinnati Electronics and Southern California Braiding have been integral to ATK throughout the development lifecycle of the SLS booster.
"Our suppliers have been vital to the success of this program," said Brasfield. "They will remain key contributors through the SLS flight test program."
ATK is an aerospace, defense, and commercial products company with operations in 22 states, Puerto Rico, and internationally. News and information can be found on the Internet at http://www.atk.com.
Certain information discussed in this press release constitutes forward-looking statements as defined in the Private Securities Litigation Reform Act of 1995. Although ATK believes that the expectations reflected in such forward-looking statements are based on reasonable assumptions, it can give no assurance that its expectations will be achieved. Forward-looking information is subject to certain risks, trends and uncertainties that could cause actual results to differ materially from those projected. Among those factors are: changes in governmental spending, budgetary policies and product sourcing strategies; the company's competitive environment; the terms and timing of awards and contracts; and economic conditions. ATK undertakes no obligation to update any forward-looking statements. For further information on factors that could impact ATK, and statements contained herein, please refer to ATK's most recent Annual Report on Form 10-K and any subsequent quarterly reports on Form 10-Q and current reports on Form 8-K filed with the U.S. Securities and Exchange Commission.
Read more here:
NASA and ATK Complete Second in Series of Key Avionics and Controls Testing for NASA's SLS Booster
When NASA's newest satellite soared into space late Wednesday (Jan. 30), a team of photographers captured dazzling views of the rocket streaking into orbit.
A series of long-exposure rocket launch photos released overnight by NASA show the unmanned Atlas 5 booster carrying the agency's new Tracking and Data Relay Satellite K (TDRS-K) as a bright arc of light climbing spaceward from a pad at Florida's Cape Canaveral Air Force Station. The rocket lifted off at 8:48 p.m. EST (0148 Jan. 31 GMT), rising like an artificial sun as it flew into space.
One image, by launch photographer Tony Gray, shows the Atlas 5 rocket just seconds after liftoff as it appeared from NASA's Kennedy Space Center, which is near the Air Force Station launch site. NASA's cavernous Vehicle Assembly Building stands stoically in the foreground as the rocket hovers in mid-flight on the photo's right side.
Another view, captured by photographer Rick Wetherington, shows the Atlas 5 rocket as a blazing arc of light as it passes behind a lighthouse at the Cape Canaveral Air Force Station.
A final image by photographer Glenn Benson shows the rocket streaking up into the night sky, its blindingly bright engine plume reflecting off the waters around the seaside launch pad.Another view, captured by photographer Rick Wetherington, shows the Atlas 5 rocket as a blazing arc of light as it passes behind a lighthouse at the Cape Canaveral Air Force Station.
The TDRS-K satellite is the first of three next-generation communications satellites to be launched in order to upgrade NASA's aging TDRS satellite constellation. The satellites serve as relays between NASA ground stations and the agency's Earth-observing satellites and other spacecraft currently orbiting the planet. TDRS-K is expected to spend at least 15 years in service once it begins operations, according to a NASA mission profile.
The first TDRS satellite was launched into space in 1983, with TDRS-K marking the 11th satellite to join the fleet. The launch provider United Launch Alliance oversaw Wednesday's Atlas 5 mission for NASA.
You can follow SPACE.com Managing Editor Tariq Malik on Twitter@tariqjmalik.Follow SPACE.com for the latest in space science and exploration news on Twitter@Spacedotcomand onFacebook.
See the article here:
Michael Woodside Promise and Perils of Nanotechnology Part I LABMP 590 Winter 2013
Dr. Michael Woodside presents Promise and Perils of Nanotechnology Part I on January 29th, 2013 in the Technology and Future of Medicine course LABMP 590 http://www.singularitycourse.com at the University of Alberta in Edmonton, Canada. Table of Contents 00 Kim Solez introduction, Personalized medicine, smart phone based wireless medicine, cryonics, 00:06:15 Michael Woodside lecture begins Promise and Perils of Nanotechnology part I, 1. Introduction, Definitions, Background, 00:13:06 Promise - stained glass, 00:14:20 nanotubes, space elevator, 00:17:40 cloaking, 00:18:15 diamondoid, 00:20:20 quantum computer, cryptography, 00:21:55 utility fog, 2. Promise and Peril at the level of science fiction and hype/doom., Constraints on the vision imposed by scientific realities, 3. Specific examples of promising, realistic, near term nanotechnology applications: Computation with quantum-dot cellular automata, Biomimetic nanotechnology (eg DNA origami) Synthetic biology, looking forward to Andrew Hessel #39;s talk "Hacking Life" on Feb. 7th at 4 pm. 4. Specific examples of realistic, near term concerns with nanotechnology. Copyright (c) 2013, Transpath Inc.
By: KimSolez
Excerpt from:
Michael Woodside Promise and Perils of Nanotechnology Part I LABMP 590 Winter 2013 - Video
Illinois NanoBio Node - CABPN Workshop - Applications of Nanotechnology useful to Food Science
Jozef L. Kokini, Professor of Food Engineering, Department of Food Science and Human Nutrition, UIUC - "Applications of Nanotechnology useful to Food Science" CABPN Workshop 11/07/12
By: NanoBio Node
Read more from the original source:
Contipro Biotech is presenting brand new device for the production of nanofibers, called 4SPIN. The device is intended for the production of nanofiber layers suitable for use both in industry and medicine.
Tokyo (PRWEB) January 31, 2013
"Contipro is registering its first success. We are a new player in the field of nanotechnology, so although we didnt expect the world to stand agape in awe before us, there is a lot of interest not only among Japanese companies, but also among the Canadians, Taiwanese, Thais and Koreans. Many of them have sought out our stand at this huge exhibition specifically because of the information in the exhibition catalogs about the specifications of our device," says Zuzana Bubnova, Contipro executive director.
"What distinguishes 4SPIN from other devices on the market is its ability to produce nanofibers from a wide range of materials. This device is not limited to one discipline or industrial area. On the one hand, 4SPIN can deal with filtration or environmental applications, and on the other it is perfectly poised to handle nanofiber materials for medicine, electronics, and other areas," says Marek Pokorny, head of the device development team, as he explains the advantages.
"It was not our original intention to develop a new device. But the market lacked equipment which can create perfectly aligned nanofibers from the human's body own substances. And because we wanted to develop new medical applications, we had to create such a device ourselves. Ultimately, we can offer this apparatus to other innovative companies and universities and prepare a pilot version of the machine that will be able to deliver the results of nanofiber research to the market," says Dr Pokorny.
The exhibition in Tokyo will last until tomorrow. According to Contipro representatives its too soon to draw conclusions. Other exhibitions in the US and Germany will give a more rounded idea of the trend, but the future of this new electrospinning device seems to be promising.
Tomas Papez Contipro Group s.r.o. (420) 606 747 097 Email Information
Go here to read the rest:
Mission Trip to Honduras - School of Medicine - Loma Linda University
A student and professor from the School of Medicine at Loma Linda University traveled to Honduras to give medical care to the local community in El Venado.
By: LomaLindaU
Excerpt from:
Mission Trip to Honduras - School of Medicine - Loma Linda University - Video
JCI #39;s Conversations with Giants in Medicine: Jeffrey Friedman
Dr. Jeffrey Friedman, of Rockefeller University, has been at the center of discovery of the molecular determinants of why we eat what we eat and, more importantly, why we eat so much of what we eat. Over the last three decades, now almost daily in the media, alarm has been sounded about the growing obesity epidemic. Dr. Friedman has spent his research career engaged in the discovery and characterization of leptin, one of the most important hormones regulating appetite and hunger.
By: jclininvest
See the original post:
JCI's Conversations with Giants in Medicine: Jeffrey Friedman - Video
Juanita J. Halls, MD, UW Health Internal Medicine
Learn more: http://www.uwhealth.org
By: UWHealthWI
Read the original here:
Ann M. McBride, MD, UW Health Internal Medicine
Learn more: http://www.uwhealth.org
By: UWHealthWI
See the rest here:
OVERLAND PARK, Kan., Jan. 31, 2013 /PRNewswire/ -- The National Operating Committee on Standards for Athletic Equipment (NOCSAE) today announced an agreement to fund $855,657 in sports medicine and concussion research. More than 85 percent of this total $727,669 specifically will focus on research to reduce athlete concussion, which is a cornerstone of NOCSAE's mission.
The NOCSAE board finalized the research funding agreement on Jan. 26, during the conclusion of the winter board meeting in Phoenix, Ariz.
NOCSAE approved $358,869 for the continued funding of three 2012 concussion-specific research grants. In addition the board tentatively approved $496,788 in new research grants, with $368,800 of that total focusing on concussion research.
"Scientific research is essential to advancing the safety of athletes of all ages and effectively addressing the issue of sports concussions," said Mike Oliver, NOCSAE executive director. "The approved research grants will support some of the top scientists and researchers in the world, and will continue to inform and evolve NOCSAE athletic equipment standards."
NOCSAE is an independent and nonprofit standard-setting body that aims to enhance athletic safety through scientific research and the creation of performance standards for protective equipment. The organization is the leading nongovernmental source for concussion-specific research funding in sports medicine and science. Since 1995 NOCSAE has devoted more than $7 million toward research by the foremost experts in sports medicine and science to develop and advance athlete safety.
More information on the 2013 grant recipients can be found at http://www.nocsae.org in the coming weeks.
About NOCSAENOCSAE, the National Operating Committee on Standards for Athletic Equipment, is an independent and nonprofit standard-setting body with the sole mission to enhance athletic safety through scientific research and the creation of performance standards for protective equipment. Formed in 1969, NOCSAE is a leading force in the effort to improve athletic equipment and, as a result, reduce injuries. NOCSAE efforts include the development of performance and test standards for football helmets, gloves and facemasks, baseball and softball batter's and catcher's helmets, baseballs and softballs, ice hockey helmets, soccer shin guards, lacrosse helmets and facemasks and polo helmets. NOCSAE is comprised of a board of directors representing stakeholders from a number of groups including consumer and end users, equipment manufacturers and reconditioners, athletic trainers, coaches, equipment managers, and academic and sports medicine associations. These diverse interests have joined forces in an attempt to arrive at a common goal of reducing sports-related injuries. NOCSAE is a nonprofit, charitable organization supported by individuals and organizations with an interest in athletics. For more information, please visit http://www.nocsae.org.
See the article here:
NOCSAE Agrees to Fund More Than $855,000 in Sports Medicine and Concussion Research
CHICAGO--(BUSINESS WIRE)--
For the last decade, Specialdocs Consultants, Inc. has been dedicated to successfully transitioning traditional medical practices to individually-designed concierge or personalized care models. During the past 10 years, Specialdocs has provided more than 100 physicians across the United Stateswith consulting, management and practice design services, along with financial processing, legal, and marketing support as they transition to a concierge practice, emphasizing personalized care.
Creating Specialdocs was my vision for allowing physicians to return to the heart of the practice of medicine - caring for their patients, notes Roberta Greenspan, Founder and President of Specialdocs Consultants, Inc. This model of care ensures that physicians are able to devote more time and resources exclusively to patient care rather than to the business of modern healthcare. Our doctors increase their average face time spent with patients from less than 10 minutes to 30 minutes or more for routine appointments.
As a seasoned healthcare executive and visionary with more than 30 years of professional experience, Greenspan founded and developed Specialdocs with the concept of bringing back patient-focused, high quality medical care to frustrated physicians and their equally frustrated patients.
As the firm celebrates its 10th anniversary, it is already focusing on the next 10 years and beyond. Specialdocs believes that every physicians practice is unique and should be designed to best serve the specific needs of patients in each individual practice. Across the county, year after year, our physicians tell us how we have changed their lives, giving them renewed enthusiasm for the clinical practice of medicine, says Greenspan. It is extremely rewarding that we have maintained longstanding relationships with our growing number of happy physician-clients.
With the adaptation of the Affordable Care Act and ACOs, our individually tailored model has continually been gaining traction, says Specialdocs Principal, Michael Friedlander. Now more than ever, physicians will need to explore their options as they navigate through new legislation and our countrys ever evolving healthcare system.
About:
Specialdocs is a medical practice consulting firm dedicated to converting traditional medical practices to personalized care or concierge models. Specialdocs is strongly invested in the concept of patient-focused medical care, working with each physician or physician group to return the physician-patient relationship to the forefront of medical services. Having successfully transitioned medical practices in 22 states across the country, their client panel has grown exclusively through satisfied physician referrals. For more information please call:847-432-4502or visit:www.specialdocs.com
Visit link:
Concierge Medicine Consulting Firm Celebrates a Decade of Personalized Care
The high cost of some western medicine is pushing more and more people to turn to alternative medicine. Jose Rodolfo Fierro is one of those people. He came to his local market in Juarez, Mexico to buy a natural herb known as cundeamor.
Im trying to get some medicine for a relative that lives in the States, El Paso. He told me to get some kind of medicine... He's a diabetic. He was told that if he was using this type of medicine he might get better. So he is willing to try, says Rodolfo Fierro.
Turns out, a lot of people in the borderland are willing to try natural herbs.
On both the U-S and Mexico side about 70 percent of the people in Juarez and El Paso use some sort of herbal medicine. That's more than double the national mainstream, says Dr. Armando Gonzalez-Stuart.
Gonzalez-Stuart works at El Paso Community College and specializes in the scientific application of herbal medicine. He says there are more than five 5,000 different medicinal plants in Mexico alone.
Walking through markets in Juarez, its easy to find plants used to treat nervous disorders, urinary problems and gastrointestinal conditions, just to name a few.
Chuchupate is the root of a plant. Its known as a very good anti-inflammatory.
Its good for the respiratory and gastrointestinal systems. And recent studies have found is be good for diabetes, says Dr. Gonzalez-Stuart.
Worldwide, only about 10 percent of all possible medicinal herbs have been studied. Some of the more common include echinacea, chamomile and St. John's wort.
It's estimated the vast majority of those taking alternative medicine in the borderland fail to tell their doctor. Some don't think it's important to share the information, while others fear their physician may dismiss the practice.
Go here to read the rest:
Public release date: 31-Jan-2013 [ | E-mail | Share ]
Contact: Lauren Woods Law2014@med.cornell.edu 646-317-7401 Weill Cornell Medical College
NEW YORK (Jan. 31, 2013) -- Recognizing that medicine is not "one size fits all," Weill Cornell Medical College and NewYork-Presbyterian Hospital have created the pioneering Institute for Precision Medicine at Weill Cornell and NewYork-Presbyterian/Weill Cornell Medical Center. This new, cutting-edge translational medicine research hub will explore the new frontier of precision medicine, offering optimal targeted, individualized treatment based on each patient's genetic profile. The institute's new genomic research discoveries will help develop novel, personalized medical therapies to be tested in innovative clinical trials, while also building a comprehensive biobank to improve research and patient care.
The Institute for Precision Medicine will be led by Dr. Mark Rubin, a renowned pathologist and prostate cancer expert who uses whole genomic sequencing in his laboratory to investigate DNA mutations that lead to disease, particularly prostate cancer. Dr. Rubin currently serves as vice chair for experimental pathology, director of Translational Research Laboratory Services, the Homer T. Hirst III Professor of Oncology, professor of pathology and laboratory medicine and professor of pathology in urology at Weill Cornell and is a pathologist at NewYork-Presbyterian/Weill Cornell.
Dr. Rubin and his team seek to replace the traditional one-size-fits-all medicine paradigm with one that focuses on targeted, individualized patient care using a patient's own genetic profile and medical history. Physician-scientists at the institute will seek to precisely identify the genetic influencers of a patient's specific illness -- such as cancer, cardiovascular disease, neurodegenerative disease and others -- and use this genetic information to design a more-effective course of treatment that targets those specific contributing factors. Also, genomic analyses of tumor tissue will enable researchers to help patients with advanced disease and no current treatment options, as well as to isolate the causes of drug resistance in patients who stop responding to treatments, redirecting them to more successful therapies.
Preventive precision medicine will also be a key initiative at the institute, allowing physician-scientists to help identify a patient's risk of diseases and take necessary steps to aid in its prevention through medical treatment and/or lifestyle modification. In addition, the Institute for Precision Medicine will leverage an arsenal of innovative genomic sequencing, biobanking and bioinformatics technology to transform the existing paradigm for diagnosing and treating patients.
"This institute will revolutionize the way we treat disease, linking cutting-edge research and next-generation sequencing in the laboratory to the patient's bedside," Dr. Rubin says. "We will use advanced technology and the collective wealth of knowledge from our clinicians, basic scientists, pathologists, molecular biologists and computational biologists to pinpoint the molecular underpinnings of disease -- information that will spur the discovery of novel treatments and therapies. It's an exciting time to be involved in precision medicine and I look forward to advancing this game-changing field of medicine."
"Precision medicine is the future of medicine, and its application will help countless patients," says Dr. Laurie H. Glimcher, the Stephen and Suzanne Weiss Dean of Weill Cornell Medical College. "The Institute for Precision Medicine, with Dr. Rubin's expertise and strong leadership, will accelerate our understanding of the human genome, provide key insights into the causes of disease and enable our physician-scientists to translate this knowledge from the lab to the clinical setting to help deliver personalized treatments to the sickest of our patients."
Three main resources will facilitate the institute's groundbreaking precision medicine work: genomics sequencing, biobanking and bioinformatics. Weill Cornell and NewYork-Presbyterian will invest in state-of-the-art technology to conduct sequencing, a more expansive biobank for all patient specimens and tissue samples and dedicated bioinformaticians who will closely analyze patient data, searching for genetic mutations and other abnormalities to identify and target with treatment.
"The Institute for Precision Medicine will enable our doctors to tailor effective treatments for individual patients and also predict the diseases that are likely to affect a patient long before they develop," says Dr. Steven J. Corwin, CEO of NewYork-Presbyterian Hospital. "By harnessing the full potential of our enhanced understanding of the human genome, and extending its reach into the clinical realm, the institute will transform patient care at NewYork-Presbyterian/Weill Cornell Medical Center and beyond."
Go here to see the original:
New Institute for Precision Medicine created at Weill Cornell and NewYork-Presbyterian
WORCESTER Craig C. Mello was the first person at University of Massachusetts Medical School to win the Nobel Prize, but he won't be the last.
This was the optimistic theme repeated by speakers at a lavish grand opening Wednesday of the $400 million new research building called the Albert Sherman Center.
Dr. Michael F. Collins, chancellor of the medical school, said the building will allow researchers to change the history of the course of diseases.
The Sherman Center was built with the help of $90 million in state funds from the Massachusetts Life Sciences Center. Elected officials, including Gov. Deval L. Patrick, called the building an important investment in the future of the life sciences industry in Massachusetts.
It is about jobs and investment, but for so many people and families, it's about hopes and cures and therapies, Lt. Gov. Timothy P. Murray said.
The Sherman Center doubles the medical school's research capacity and will bring under one roof researchers who currently work in different locations. The building was designed to encourage collaboration.
Researchers have started moving into their new labs, a process that will continue through April. UMass has recruited many top-flight scientists over the last five years to work in the new building. Through stem cells, gene therapy, RNA interference and other types of research, they're working on treatments for a variety of ailments including cancer, diabetes, heart disease and amyotrophic lateral sclerosis, or ALS.
The facility, House Speaker Robert A. DeLeo said, represents the best of what we in government can do.
U.S. Rep. James P. McGovern joked that he was so excited with what he saw in the more-than-500,000 square-foot building that he wanted to donate his body to medical research.
The building is named for Albert Albie Sherman, who formerly served as UMass vice chancellor of university relations and is well-known in political circles.
See original here:
Newswise New Brunswick, NJ Three members of the University of Medicine and Dentistry of New Jersey-Robert Wood Johnson Medical School faculty have been named 2013 recipients of the prestigious Edward J. Ill Excellence in Medicine Awards, highlighting their expertise as exceptional educators or researchers.
These honorees are: Suhayl Dhib-Jalbut, MD, professor and chair, Department of Neurology, Robert Wood Johnson Medical School, and chief, Neurology Service, Robert Wood Johnson University Hospital, who will receive the Outstanding Medical Research Scientist Award for Clinical Research. Dr. Dhib-Jalbut, a resident of Princeton, conducts research in the area of multiple sclerosis, funded by the National Institutes of Health and the National MS Society. He is currently president-elect of ACTRIMS, the Americas Committee for Treatment and Research in Multiple Sclerosis, a prestigious international organization. Smita S. Patel, PhD, professor, Department of Biochemistry and Molecular Biology, who will receive the Outstanding Medical Research Scientist Award for Basic Biomedical Research. Dr. Patel's recent research includes studies of helicase and polymerase enzymes in mitochondrial DNA replication and transcription, and in recognition of viruses for antiviral immune response. Dr. Patel lives in Whitehouse Station. Carol A. Terregino, MD, senior associate dean for education (interim) and associate dean for admissions and student affairs at Robert Wood Johnson Medical School, who will receive the Outstanding Medical Educator Award. A Cranford native who currently lives in Mt. Laurel, Dr. Terregino also serves as the senior associate dean for admissions (interim) for the Camden regional campus.
2013 marks the fifth consecutive year in which Robert Wood Johnson Medical School faculty members will be honored for their work as medical research scientists.
Named for a New Jersey physician who pioneered the promotion of continuing education in ways that set the national standard, the Edward J. Ill Excellence in Medicine Awards--created in 1939--honors exemplary New Jersey physicians whose dedication to education, research, and public service have significantly impacted the delivery of health care state- and nationwide. Since 2003, the annual awards have been sponsored by the MDAdvantage Insurance Company of New Jersey.
In addition to the honors listed above, recognition is also given in the following categories: Outstanding Medical Executive Award, Edward J. Ill Physician's Award, Verice M. Mason Community Service Leader Award, and the Peter W. Rodino Jr. Citizen's Award. This year's awards will be presented during a May 1 ceremony at Greenacres Country Club in Lawrenceville.
More information about the awards and the upcoming ceremony can be found online at the Edward J. Ill Excellence in Medicine Foundation website, http://www.EJIawards.org, or by calling 609-803-2350.
About UMDNJ-Robert Wood Johnson Medical School As one of the nation's leading comprehensive medical schools, Robert Wood Johnson Medical School is dedicated to the pursuit of excellence in education, research, health care delivery, and the promotion of community health. In cooperation with Robert Wood Johnson University Hospital, the medical school's principal affiliate, they comprise one of the nation's premier academic medical centers. In addition, Robert Wood Johnson Medical School has 34 other hospital affiliates and ambulatory care sites throughout the region.
As one of the eight schools of the University of Medicine and Dentistry of New Jersey, with 2,800 full-time and volunteer faculty, Robert Wood Johnson Medical School encompasses 22 basic science and clinical departments, and hosts centers and institutes including The Cancer Institute of New Jersey, the Child Health Institute of New Jersey, the Center for Advanced Biotechnology and Medicine, the Environmental and Occupational Health Sciences Institute, and the Stem Cell Institute of New Jersey. The medical school maintains educational programs at the undergraduate, graduate and postgraduate levels for more than 1,500 students on its campuses in New Brunswick, Piscataway, and Camden, and provides continuing education courses for health care professionals and community education programs. To learn more about Robert Wood Johnson Medical School, visit rwjms.umdnj.edu. Find us online at http://www.Facebook.com/RWJMS and http://www.twitter.com/UMDNJ_RWJMS. --#--
Read more here:
Three Robert Wood Johnson Medical School Faculty to be Honored for Excellence in Medicine
The University of Texas at Austin hopes to enroll its first class of medical students on its campus by 2016 with the help of a $50 million gift from the Michael & Susan Dell Foundation.
The Dell Foundation announced on Wednesday a $50 million commitment to establish the Dell Medical School at UT-Austin. The foundation has promised to donate another $10 million to Austin and Travis County community health quality and access programs over the next 10 years.
"This gift truly saves lives," said Francisco Cigarroa, UT System Chancellor, who is also a transplant surgeon. "Investments in medical education, biomedical research and health care touch all citizens."
In November, Travis County voters approved a property-tax increase that included a plan to build a research-based medical school on UT-Austin's campus.
The Dell Medical School is scheduled to enroll its first class of 50 students in 2016, according to a news release.
"UT is a world class university, an the medical school will be able to attract top talent, advance medical research and practices and improve family health for generations to come," said Susan Dell, co-founder and board chair of the foundation."
Read the rest here:
Gift from Dell Foundation will help launch UT-Austin medical school